feed,title,long_url,short_url
SeekingAlpha,Takeda buoyed by mid-stage trial for immune disorder treatment mezagitamab,https://seekingalpha.com/news/4079110,
SeekingAlpha,Elon Muskâ€™s TSLA is now the worst performing S&P 500 stock YTD,https://seekingalpha.com/news/4079026,
